Literature DB >> 9402372

Questions and answers about defensins.

R I Lehrer.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9402372     DOI： 10.1086/516082

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways.

Authors:  M Edgerton; S E Koshlukova; M W Araujo; R C Patel; J Dong; J A Bruenn
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

2.  The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda.

Authors:  François Hakizayezu; Emmanuel Biracyaza; Hosee Niyompano; Aline Umubyeyi
Journal:  HIV AIDS (Auckl)       Date:  2022-08-12

3.  Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.

Authors:  Aisling S Dugan; Melissa S Maginnis; Joslynn A Jordan; Megan L Gasparovic; Kate Manley; Rebecca Page; Geoffrey Williams; Edith Porter; Bethany A O'Hara; Walter J Atwood
Journal:  J Biol Chem       Date:  2008-09-09       Impact factor: 5.157

4.  The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid.

Authors:  Stephen R Zins; Christian D S Nelson; Melissa S Maginnis; Rahul Banerjee; Bethany A O'Hara; Walter J Atwood
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

5.  Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients.

Authors:  Ehab H Mattar; Hussein A Almehdar; Abdullah A AlJaddawi; Isam ElDin M Abu Zeid; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2016-06-20       Impact factor: 4.818

6.  Low concentrations of human neutrophil peptide ameliorate experimental murine colitis.

Authors:  Takuro Maeda; Toshio Sakiyama; Shuji Kanmura; Shinichi Hashimoto; Kazunari Ibusuki; Shiroh Tanoue; Yuga Komaki; Shiho Arima; Yuichiro Nasu; Fumisato Sasaki; Hiroki Taguchi; Masatsugu Numata; Hirofumi Uto; Hirohito Tsubouchi; Akio Ido
Journal:  Int J Mol Med       Date:  2016-11-03       Impact factor: 4.101
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.